Friedemann Schmidt

Sanofi R&D
Frankfurt Am Main, HE 65926, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

HyperSBINN: A Hypernetwork-Enhanced Systems Biology-Informed Neural Network for Efficient Drug Cardiosafety Assessment.

HyperSBINN: A Hypernetwork-Enhanced Systems Biology-Informed Neural Network for Efficient Drug Cardiosafety Assessment.

Journal: Journal of computational biology : a journal of computational molecular cell biology

Published: January 30, 2026

Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety.

Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety.

Journal: Nature reviews. Drug discovery

Published: September 17, 2025

Quantitative assessment of the usability of electromechanical human-based modelling and simulation to replace Langendorff isolated rabbit heart experiments in the preclinical setting.

Quantitative assessment of the usability of electromechanical human-based modelling and simulation to replace Langendorff isolated rabbit heart experiments in the preclinical setting.

Journal: Frontiers in pharmacology

Published: July 22, 2025

Shaping secondary pharmacology panels of the future: evolving target selection criteria for safety panels.

Shaping secondary pharmacology panels of the future: evolving target selection criteria for safety panels.

Journal: Nature reviews. Drug discovery

Published: April 22, 2025

Machine learning enhances genotoxicity assessment using MultiFlow® DNA damage assay.

Machine learning enhances genotoxicity assessment using MultiFlow® DNA damage assay.

Journal: Environmental and molecular mutagenesis

Published: October 08, 2024

Evaluation of the nitrosamine impurities of ACE inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potential.

Evaluation of the nitrosamine impurities of ACE inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potential.

Journal: Environmental and molecular mutagenesis

Published: June 28, 2024

Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines.

Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines.

Journal: Nature reviews. Drug discovery

Published: June 17, 2024

The state of the art in secondary pharmacology and its impact on the safety of new medicines.

The state of the art in secondary pharmacology and its impact on the safety of new medicines.

Journal: Nature reviews. Drug discovery

Published: April 05, 2024

Developing a pragmatic consensus procedure supporting the ICH S1B(R1) weight of evidence carcinogenicity assessment.

Developing a pragmatic consensus procedure supporting the ICH S1B(R1) weight of evidence carcinogenicity assessment.

Journal: Frontiers in toxicology

Published: January 13, 2024

Can immersive olfactory training serve as an alternative treatment for patients with smell dysfunction?

Can immersive olfactory training serve as an alternative treatment for patients with smell dysfunction?

Journal: Laryngoscope investigative otolaryngology

Published: December 22, 2023

Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection.

Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection.

Journal: Ear, nose, & throat journal

Published: March 28, 2023

Predicting DNA-Reactivity of N-Nitrosamines: A Quantum Chemical Approach.

Predicting DNA-Reactivity of N-Nitrosamines: A Quantum Chemical Approach.

Journal: Chemical research in toxicology

Published: October 27, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026